Patient‐Focused Drug Development Methods for Benefit–Risk Assessments: A Case Study Using a Discrete Choice Experiment for Antiepileptic Drugs

Regulatory decisions may be enhanced by incorporating patient preferences for drug benefit and harms. This study demonstrates a method of weighting clinical evidence by patients’ benefit–risk preferences. Preference weights, derived from discrete choice experiments, were applied to clinical trial da...

Descripción completa

Detalles Bibliográficos
Autores principales: Holmes, Emily A.F., Plumpton, Catrin, Baker, Gus A., Jacoby, Ann, Ring, Adele, Williamson, Paula, Marson, Anthony, Hughes, Dyfrig A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491963/
https://www.ncbi.nlm.nih.gov/pubmed/30204252
http://dx.doi.org/10.1002/cpt.1231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491963/
https://www.ncbi.nlm.nih.gov/pubmed/30204252
http://dx.doi.org/10.1002/cpt.1231

Ejemplares similares